Mechanisms of Eosinophil Effector Functions in the Lung
肺中嗜酸性粒细胞效应功能的机制
基本信息
- 批准号:7632048
- 负责人:
- 金额:$ 12.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAgonistAllergensAllergicAntibodiesAsthmaBiological ModelsBiologyBiomedical ResearchClinicCytoplasmic GranulesDevelopmentDevelopment PlansDiphtheria ToxinDoctor of PhilosophyEducational ActivitiesFoundationsGene TransferGenesGoalsGraduate EducationHumanInflammationInterleukin-5Knockout MiceLaboratoriesLaboratory ResearchLungLung diseasesMediatingModelingMolecular BiologyMusPathologyPatientsPhysiologyProteinsPulmonary PathologyReagentRecruitment ActivityResearchRoleSmall inducible cytokine A24TechnologyTrainingTransgenic ModelTransgenic OrganismsUniversitiesWorkbasecareercareer developmentchemokineeosinophilexpectationexperiencehuman diseasenovelprogramssuccess
项目摘要
The use of gene transfer technologies and the mouse as a model of human respiratory diseases aptlysummarizes
the research program of the candidate, James (Jamie) J-.ee, Ph.D. This work forms the basis of the candidate's
immediate career goals of expanding the breadth of his laboratory to includeincreasinglycomplex assessmentsof
physiologically relevant endpoints of pathology. The achievement of these immediate goals, in turn, support the
long term goals, including (i) To move the orientation of the lab from a molecular biology perspective to a
physiology-based program and (ii)To expand the educational activities in mouse research within the Mayo
Foundation, and Mayo ClinicArizona in particular,and to includethe regional graduate program at ArizonaState
Uni versity. The institutional support and commitmentto research and graduate education offered byMayo Clinic,
together with the expanding local university graduate programs in biomedical research, represent unique
opportunities to create a collaborative center of focused efforts using the mouse as a model system of human
disease research. A critical objective of this career development plan is to recruit and train motivatedstudents
and fellows, capitalizing on the success of the laboratory's research activities.The goals of the researchproposal
are to define the role(s) of eosinophils and eosinophil effector functions mediating allergic inflammation and,
therefore, their roles in the development of pulmonary pathologies. The proposal exploits unique eosinophil-
specific reagents and novel transgenic and gene knockout mice we have created in our studies ofeosinophil
biology. The objectives will be achieved through the completion of the following aims: (1) To determine
unequivocally the contribution(s)of eosinophils to the pulmonarypathologies arising in a transgenic model of
asthma generated by the co-expression of JJL-5 and eotaxin-2; (2) To define mechanisms of eosinophil effector
functions responsible for the pulmonarypathologiesoccurring in the IL-5/eotaxin-2 transgenicmodel of asthma;
(3) To determine if degranulation and the release of granule proteins represents a mechanism by which
eosinophils contribute to the pathologies arising in the IL-5/eotaxin-2 transgenic model of asthma.
基因转移技术的使用和小鼠作为人类呼吸道疾病模型的应用恰当地总结了
研究计划的候选人,詹姆斯(杰米)J-.ee,博士。这项工作构成了候选人的基础
近期的职业目标是扩大他的实验室的广度,包括越来越复杂的评估,
病理学的生理学相关终点。这些近期目标的实现反过来又支持了
长期目标,包括(i)将实验室的方向从分子生物学的角度转变为
(ii)在马约内扩大小鼠研究的教育活动
基金会,特别是亚利桑那州的马约诊所,并包括亚利桑那州立大学的区域研究生课程
大学。梅奥诊所对研究和研究生教育的机构支持和承诺,
与不断扩大的当地大学研究生课程在生物医学研究,代表了独特的
利用鼠标作为人类的模型系统,
疾病研究。本职业发展计划的一个关键目标是招募和培养有动力的学生
和研究员,利用实验室的研究活动的成功。
是为了确定嗜酸性粒细胞和嗜酸性粒细胞效应功能介导过敏性炎症的作用,
因此,它们在肺部病理学发展中的作用。这项提案利用了独特的嗜酸性粒细胞-
我们在嗜酸性粒细胞研究中创建的特定试剂和新型转基因和基因敲除小鼠
生物学这些目标将通过完成以下目标来实现:(1)确定
明确的是,嗜酸性粒细胞对在转基因肺肿瘤模型中出现的肺部病理的贡献。
研究JJL-5和Eotaxin-2共表达对哮喘发病的影响;(2)探讨Eotaxin-2与JJL-5共表达的作用机制
在IL-5/eotaxin-2转基因哮喘模型中引起肺病理学的功能;
(3)为了确定脱粒和颗粒蛋白的释放是否代表了一种机制,
嗜酸性粒细胞导致哮喘的IL-5/嗜酸性粒细胞活化趋化因子-2转基因模型中出现的病理。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Joseph LEE其他文献
JAMES Joseph LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Joseph LEE', 18)}}的其他基金
Efficacy of BCG Therapy is a Function of Bladder Tumor Immune Microenvironment
卡介苗治疗的疗效是膀胱肿瘤免疫微环境的函数
- 批准号:
8685912 - 财政年份:2013
- 资助金额:
$ 12.1万 - 项目类别:
Efficacy of BCG Therapy is a Function of Bladder Tumor Immune Microenvironment
卡介苗治疗的疗效是膀胱肿瘤免疫微环境的函数
- 批准号:
8580152 - 财政年份:2013
- 资助金额:
$ 12.1万 - 项目类别:
Asthma is a Prognostic Indicator for Pulmonary Metastasis of Breast Cancer
哮喘是乳腺癌肺转移的预后指标
- 批准号:
7943034 - 财政年份:2009
- 资助金额:
$ 12.1万 - 项目类别:
Eosinophil Recruitment and Activation in Solid Tumors
实体瘤中嗜酸性粒细胞的募集和激活
- 批准号:
7908321 - 财政年份:2009
- 资助金额:
$ 12.1万 - 项目类别:
Asthma is a Prognostic Indicator for Pulmonary Metastasis of Breast Cancer
哮喘是乳腺癌肺转移的预后指标
- 批准号:
7787921 - 财政年份:2009
- 资助金额:
$ 12.1万 - 项目类别:
Mechanisms of Eosinophil Effector Functions in the Lung
肺中嗜酸性粒细胞效应功能的机制
- 批准号:
6924952 - 财政年份:2005
- 资助金额:
$ 12.1万 - 项目类别:
Eosinophil Recruitment and Activation in Solid Tumors
实体瘤中嗜酸性粒细胞的募集和激活
- 批准号:
7540370 - 财政年份:2005
- 资助金额:
$ 12.1万 - 项目类别:
Eosinophil Recruitment and Activation in Solid Tumors
实体瘤中嗜酸性粒细胞的募集和激活
- 批准号:
6860565 - 财政年份:2005
- 资助金额:
$ 12.1万 - 项目类别:
Eosinophil Recruitment and Activation in Solid Tumors
实体瘤中嗜酸性粒细胞的募集和激活
- 批准号:
7006104 - 财政年份:2005
- 资助金额:
$ 12.1万 - 项目类别:
Mechanisms of Eosinophil Effector Functions in the Lung
肺中嗜酸性粒细胞效应功能的机制
- 批准号:
7072211 - 财政年份:2005
- 资助金额:
$ 12.1万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 12.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 12.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 12.1万 - 项目类别: